1. Signaling Pathways
  2. GPCR/G Protein
  3. Adenosine Receptor
  4. Adenosine Receptor Inhibitors

Adenosine Receptor Inhibitors

Adenosine A1 receptor (A1R)

Adenosine A2A receptor (A2AR)

Adenosine A2B receptor (A2BR)

Adenosine A3 receptor (A3R)

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Adenosine Receptor Inhibitors, Agonists, Antagonists & Modulators
Product Name Adenosine A1 receptor (A1R) Adenosine A2A receptor (A2AR) Adenosine A2B receptor (A2BR) Adenosine A3 receptor (A3R) Purity
Inosine
A1AR
A2AR
    ≥98.0%
ZM241385  
A2AR, Ki: 1.4 nM
    99.26%
Derenofylline
A1R, Ki: 1 nM
A2AR, Ki: 398 nM
 
Adenosine A3 receptor, Ki: 200 nM
99.87%
Adenosine 5'-monophosphate disodium    
A2BR
  99.63%
AB-MECA      
Adenosine A3 receptor
98.01%
2-Chloro-N-cyclopentyl-2′-C-methyladenosine
A1AR
      99.79%
DPTN dihydrochloride      
hA3, Ki: 1.65 nM
98.66%
M1069  
A2AR
A2BR
  98.04%
MIPS521
A1AR
      99.65%
PSB36
rA1, Ki: 0.12 nM
rA2A, Ki: 552 nM
hA2B, Ki: 187 nM
hA3, Ki: 2300 nM
rA3, Ki: 6500 nM
≥99.0%
ANR94  
A2AR, Ki: 46 nM (human)
   
MRS1334
rA1, Ki: >100 nM
rA2A, Ki: >100 nM
 
hA3, Ki: 2.69 nM
≥99.0%
Adenosine receptor antagonist 2  
A2a adenosine receptor, IC50: 1 nM
A2b adenosine receptor, IC50: 3 nM
    99.37%
FR194921
A1R, Ki: 6.6 nM
A2AR, Ki: 5400 nM
    98.10%
VUF-5574      
Recombinant Human Adenosine A3 receptor (A3R) , Ki: 4.03 nM
99.41%
PSB-1115    
A2BR
  ≥99.0%
Adenosine receptor inhibitor 2
A1AR, Ki: 52.2 ± 8.5 nM
A2AR, Ki: 167 ± 22 nM
hA2B, Ki: >1000 nM
Adenosine A3 receptor, Ki: >1000 nM
A1AR antagonist 5
hA1AR, pKi: 6.11
hA2AAR, pKi: <4
   
Adenosine receptor inhibitor 1
A1AR, Ki: >1000 nM
A2AR, Ki: 68.5 nM
hA2B, Ki: >1000 nM
Adenosine A3 receptor, Ki: >1000 nM
ST 1535  
A2a adenosine receptor
   
A1AR antagonist 4
hA1AR, pKi: 6.29
hA2AAR, pKi: <4
   
PSB11 hydrochloride      
human A3, Ki: 2.3 nM
hA3AR agonist 1      
Adenosine A3 receptor, Ki: 2.40 nM
LAS38096
A1, Ki: >1000 nM
A2A, Ki: >2500 nM
A2B, Ki: 17 nM
A3, Ki: >1000 nM
LJ-4517  
A2AR, Ki: 18.3 nM
   
LUF5834
A1R, Ki: 2.6 nM
A2AR, Ki: 28 nM
A2BR, EC50: 12 nM
 
A3AR antagonist 3
hA1AR, Ki: 2.22 μM
hA2AAR, Ki: 7.73 μM
 
hA3, Ki: 37 nM
SCH-202676      
Adenosine A3 receptor
A3AR modulator 1      
Adenosine A3 receptor
A1AR antagonist 6
hA1AR, pKi: 7.13
hA2AAR, pKi: <4
   
A2AAR antagonist 2  
A2a adenosine receptor, IC50: 33.5 nM
   
ISAM-140    
hA2B, Ki: 3.49 nM
 
A2A receptor antagonist 3
A1R, Ki: 107 nM
A2AR, Ki: 0.4 nM
A2BR, Ki: 37 nM
A3R, Ki: 1467 nM
hA2A/hCA XII modulator 1
hA1AR, Ki: 4.819 μM
hA2AAR, Ki: 6.4 nM
 
hA3, Ki: >30 μM
A2AR-antagonist-1  
A2AR, IC50: 29 nM
   
VCP171
A1R
     
A2AAR/HDAC-IN-1
A1AR, Ki: 503.3 ± 14 nM
A2AR, Ki: 163.5 ± 14 nM
hA2B, Ki: >10000 nM
Adenosine A3 receptor, Ki: >10000 nM
(E)-8-(3-Chlorostyryl)caffeine  
A2AR
   
Neladenoson dalanate hydrochloride
A1R
     
A2A receptor antagonist 2  
A2AR, IC50: 8.3 nM
   
A3AR antagonist 1      
hA3, Ki: 4.63 nM
A3AR antagonist 2      
hA3, Ki: 4.54 nM
Neladenoson dalanate
A1R
     
MRS5698      
Adenosine A3 receptor, Ki: ~3 nM
A2A/A3 AR antagonist-1  
hA2AAR, Ki: 90 nM
 
hA3, Ki: 31.8 nM
A1AR antagonist 3
human A1, Ki: 9.69 nM
rat A1, Ki: 0.529 nM
     
A1/A3 AR antagonist 1
human A1, Ki: 36.7 nM
rat A1, Ki: 1.47 nM
   
human A3, Ki: 25.4 nM
Adenosine receptor antagonist 1  
A2AR, IC50: 0.29 nM